一、 招聘岗位

研究方向（1）：医学X射线定量成像及医学影像深度分析

合作导师（浙江大学）及团队简介

牛田野，浙江大学转化医学研究院和附属邵逸夫医院双聘教授、博导，浙江省海外高层次人才引进计划特聘专家，科技部863计划“青年科学家”，美国新泽西州立大学罗格斯分校放射肿瘤学系兼职副教授、美国应用临床医学物理期刊（SCI收录）编委、美国医学物理与工程类顶级期刊Physics in Medicine & Biology期刊（SCI收录）国际咨询委员、中国生物医学工程学会医学物理分会和精准放疗技术分会委员。其团队主要从事多学科交叉的医学工程研究，致力于设计图像定量化分析技术用于临床肿瘤治疗评估，包括基于临床病例数据集的肿瘤治疗疗效评估、超低剂量双能CT用于人体组织精准识别等。

合作导师（斯坦福大学）及团队简介

邢磊，斯坦福大学医学院放射肿瘤学系教授，Jacob Haimson讲席教授，放射肿瘤系医学物理学部主任，美国医学物理学会院士，电子工程系客座教授。分子影像、Bio-X和癌症生物学项目成员。其团队致力于医学物理和医学影像技术的研究和应用，创建和领导了国际上第一个集成医学物理、纳米医学和分子影像的研究中心，该中心也是第一个把放射肿瘤治疗学与分子影像学相结合的转化研究中心。

联合招收博士后工作计划

第一年，在浙江大学牛田野教授课题组开展医学成像和图像处理的研发工作，设计X射线断层功能成像方法，构建成像-治疗一体化数据分析评估体系。第二年，在斯坦福邢磊教授课题组深入研究功能成像在临床治疗引导和评估中的作用，构建肿瘤治疗的多模态影像评估系统。

研究方向（2）：胃肠道肿瘤的靶向及免疫治疗的转化医学研究

研究方向（3）：长寿的转化医学研究

合作导师（浙江大学）及团队简介

闵军霞，肿瘤学博士，博士生导师，浙江大学转化医学研究院特聘教授。2006年美国密苏里哥伦比亚大学生物学博士；2006-2010年哈佛大学医学院医学遗传系博士后；2010-2014年任诺华（Novartis，美国）肿瘤部新药研发团队负责人，主要负责整合分析多种组学大数据发现肿瘤新型分子靶标及CAR-T的优化研究。 2014年加盟浙江大学医学院并入选浙江省海外高层次“浙江省****”创新学者及“浙江省特聘专家”。多年来主要运用医学及生命科学前沿技术开展肿瘤的转化医学研究。在Nature Medicine、Hepatology、PNAS等著名期刊发表论文40余篇，多次应邀在国内外学术大会及著名大学院所进行主旨报告。先后承担国家自然科学基金项目及科技部国家重点研发计划等。更多信息请见闵军霞老师个人主页：https://person.zju.edu.cn/Junxia

合作导师（斯坦福大学）及团队简介

程震教授，现为美国斯坦福大学分子影像中心肿瘤分子影像化学实验室主任，斯坦福大学医学院分子影像中心、克莱瑞-斯坦福癌症早期检测研究中心、斯坦福癌症研究所、放射科及BioX中心副教授。长期从事肿瘤分子影像技术、多模态分子探针的研制和开发, 至今发表论文230余篇, H-因子61，引用超过12800次（Google学术）。程震教授在肿瘤分子影像探针及纳米药物研发及转化方面研究成果卓著。

联合招收博士后工作计划

第一年，在浙江大学开展消化系统肿瘤的靶点筛选、分子机制、信号网络及代谢调控等研究工作。第二年，在斯坦福大学进一步深入研究肿瘤靶向及免疫治疗的分子机制及精准治疗新策略。完成论文撰写并在高水平期刊上发表研究成果。

二、 岗位要求

1、近三年内获得国内C9高校或第四轮学科评估A+学科或海外顶尖大学博士学位；

2、身体健康，年龄不超过32周岁；

3、有良好的学术表现及学术发展潜力，未来有志于到浙江大学从事教学科研工作。

三、 工作方式及待遇

该岗位招聘1人。入选者在双方合作导师指导下开展研究工作，根据浙江大学博士后管理工作规定完成相应的考核，完成研究工作并达到相应学科的博士后出站要求后办理出站。在海外合作发表的学术论文及其他成果可认定为出站成果，鼓励入选者与海外高水平研究人员和合作教授联合发表论文，第一署名单位及排名不计先后。

项目资助期为2年，学校、学院和合作导师给予每人26-28万/年的资助。入选者公派赴斯坦福大学工作期间，学校再给予每人10万元补充资助，其他补充资助视情况再定。入选者在资助期内享受学校学科博士后相关福利。

入选者在聘期内学术能力和业绩表现优秀者，出站后可申请学校“百人计划”或特聘研究员岗位，进入浙江大学预聘师资队伍。

四、 应聘程序

发送个人简历（包括个人基本信息、学习工作经历、参与科研项目、科研成果），代表性论文及其他能证明科研能力的材料至联系人邮箱，经面试小组综合评估通过后报浙江大学审批。经学校批准录用人员，须登录中国博士后网注册，并按浙江大学博士后进站程序办理进站。

本次招聘报名截止日期：2019年10月17日

联系人：常老师

联系电话：+86-571-88981338

E-mail: changle196@zju.edu.cn（邮件主题标明为“姓名+应聘岗位+教育科研人才网”）

Joint Postdoctoral Fellowship Program: Zhejiang University School of Medicine and Stanford University

I. Position

Research Area (1): Medical X-ray quantitative imaging and deep analysis

Supervisor at Zhejiang University:

NIU Tianye, jointly employed full professor at Institute of Translational Medicine and Sir Run Run Shaw Hospital, Zhejiang University, Ph. D. supervisor, Ministry of Science and Technology 863-Plan “Young Scientist”, adjunct associate professor at Department of Radiation Oncology, the State University of New Jersey, Rutgers, editorial board of Journal of Applied Clinical Medical Physics (SCI), international advisory committee of Physics in Medicine & Biology (top medical physics SCI journal), committee of the Medical Physics and Precision Radiotherapy Technology Branch of Chinese Society of Biomedical Engineering (CSBE). His group is mainly engaged in multidisciplinary medical engineering research, dedicated to the design of image quantitative analysis technology for clinical tumor treatment evaluation, including tumor treatment response evaluation based on clinical case dataset, ultra-low dose dual energy CT for human tissue precision identification, etc.

Supervisor at Stanford University：

XING Lei is currently the Jacob Haimson Professor of Medical Physics and Director of Medical Physics Division of Radiation Oncology Department at Stanford University. He also holds affiliate faculty positions in Department of Electrical engineering, Bio-X and Molecular Imaging Program at Stanford. Dr. Xing’s research has been focused on medical imaging, artificial intelligence in medicine, treatment planning, image guided interventions, nanomedicine, and applications of molecular imaging in radiation oncology. He has made unique and significant contributions to each of the above areas. Dr. Xing is an author on more than 300 peer reviewed publications, a co-inventor on many issued and pending patents, and a co- investigator or principal investigator on numerous NIH, DOD, RSNA, ACS and corporate grants. He is a fellow of AAPM (American Association of Physicists in Medicine) and AIMBE (American Institute for Medical and Biological Engineering). He is a recipient of Google Faculty Scholar Award. He is also on the editorial boards of a number of journals in medical physics and medical imaging.

Work Plans (Tentative Schedule):

Year 1: Conduct research on medical imaging and image processing and design the computed tomography image reconstruction scheme in the Professor Niu’s group at Zhejiang University;

Year 2: Develop the tumor evaluation system based on multimodalities images with the assistance from the research group of Professor Xing Lei from Stanford.

Research Area (2): Translational medical research of gastroenterology cancer

Research Area (3): Translational medical research of longevity

Supervisor at Zhejiang University:

Junxia Min M.D., Ph.D. currently serves as a professor at Institute of Translational Medicine & The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. Prof. Min earned her Ph.D. from University of Missouri-Columbia in the United States in 2006. The key finding during her PhD training was discovered the important roles of sphingolipid metabolic pathway in cancer treatment. From 2006-2010, Dr. Min had her postdoctoral training at the Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School. She identified the important novel epigenetic regulatory mechanisms in tumorigenesis. Since 2010, Dr. Min joined Novartis Department of Oncology as a group leader at Boston, U.S.A., where her group discovered and functionally validated several novel targets for further clinical drug development. In aging research area, Prof. Min has been co-leading genetic contributions of the world largest centenarian cohort “The Chinese Longitudinal Healthy Longevity Study (CLHLS)”. Based on this 20-year longitudinal cohort study, the team has uncovered key genetic factors that associated with longevity.

Supervisor at Stanford University：

Prof. Zhen Cheng serves as the Director of Molecular Imaging Program at Stanford (MIPS) (2007 - Present) and member of Bio-X Program, Stanford Cancer Center, and Canary Center at Stanford for Cancer Early Detection (2009 - Present). Cheng lab has been working on identification of novel cancer biomarkers with significant clinical relevance, to develop new chemistry for probes preparation, and to validate new strategies for probes high-throughput screening. The goal of Cheng laboratory is to develop novel molecular imaging probes and techniques for non-invasive detection of cancer and its metastasis at the earliest stage, so that cancer can be cured or transformed into a chronic, manageable disease. The techniques developed in Cheng research will allow a close examination of the molecular, metabolic and physiological characteristics of cancers and their responses to therapy. Prof Cheng has published over 250 research articles, H-index 61，citation >12800(Google scholar).

Work Plans (Tentative Schedule):

Year 1: Working with Prof. Junxia Min at Zhejiang University to study on identification of novel cancer therapeutic targets, molecular regulatory mechanisms, signaling networks， metabolic regulation and clinical implications of precision cancer diagnosis and treatment.

Year 2: Working with Prof. Zhen Cheng at Stanford University to explore underlying molecular mechanisms and to develop novel strategies for effective cancer therapeutics. Prepare and submit manuscripts for publication.

II. Eligibility

1. A Ph.D. degree within the recent three years from domestic C9 universities, or from “A plus” disciplines of the fourth round of national discipline assessment by China Academic Degree & Graduate Education Development Center, or from top overseas universities.

2. The applicants shall be under 32 years old, of good moral character, and in good health.

3. Good academic performance and research capability. Interested in teaching and research positions at Zhejiang University in the future.

III. Assessment requirements and Funding

One quota for this position. The selected candidates will carry out research work under the guidance of the cooperative supervisors of both universities. The candidates shall fulfill the corresponding assessments according to the post-doctoral management regulations of Zhejiang University, complete the research work, and reach the post-doctoral requirements of the corresponding disciplines. The selected candidates are encouraged to jointly publish articles with professors at Stanford University. Academic papers and other achievements published together with professors at Stanford University can be regarded as the achievements of the postdoctoral program.

The selected candidates will be funded for two years. The full salary will be 260,000-280,000 RMB per year from Zhejiang University, School of Medicine, and supervisor. An additional grant of 100,000 RMB will be supplied during the period of work at Stanford University by Zhejiang University. Selected candidates will also enjoy the benefits of the common postdoctoral program at Zhejiang University in projects application.

Qualified selected candidates may apply for the “Hundred Talents Program” or Distinguished Research Fellow (ZJU tenure track positions) after completion of the program.

IV. Application Procedures

Send a resume (including basic personal information, study and work experiences, participation in research projects, publication list, etc.), representative papers and other materials to the bottom email address. After comprehensively evaluating through interview processes and discussing with the professor at Stanford University, the result will be reported to Zhejiang University for approval. Upon successful application, the selected candidates shall finish the registration procedures and will be subject to the management of Zhejiang University.

Application Deadline：17 October，2019

Contacts

Ms. Chang

Contact numbers: +86-571-88981338

E-mail: changle196@zju.edu.cn

原文出处：

http://hr.zju.edu.cn/postdoctor/2019/0917/c29115a1674623/page.htm

内容出处：